Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$150M |
| 2 |
Johnson Controls International
JCI
|
+$145M |
| 3 |
ExxonMobil
XOM
|
+$135M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$437M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$146M |
| 3 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$108M |
| 4 |
Danaher
DHR
|
+$103M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$84.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.06% |
| 2 | Financials | 14.21% |
| 3 | Healthcare | 14.12% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBMG
2976
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $825K | ﹤0.01% |
56,899
+1,477
| +3% | +$21K |
|
2977
ACNB Corp
ACNB
$655M
| $824K | ﹤0.01% |
31,002
+4,062
| +15% | +$107K |
|
|
RGLS
2978
DELISTED
Regulus Therapeutics
RGLS
| $824K | ﹤0.01% |
2,081
+422
| +25% | +$174K |
|
|
NVO
2979
Novo Nordisk
NVO
$209B
| $823K | ﹤0.01% |
39,612
-5,408
| -12% | -$134K |
|
|
GLV
2980
Clough Global Dividend & Income Fund
GLV
$78.1M
| $822K | ﹤0.01% |
+67,841
| New | +$814K |
|
2981
Home Bancorp
HBCP
$566M
| $821K | ﹤0.01% |
29,357
+4,095
| +16% | +$116K |
|
|
HDNG
2982
DELISTED
Hardinge Inc
HDNG
| $821K | ﹤0.01% |
73,810
+8,721
| +13% | +$91.7K |
|
|
MOBL
2983
DELISTED
MobileIron, Inc.
MOBL
| $819K | ﹤0.01% |
298,181
+4,304
| +1% | +$13.3K |
|
2984
Greif Class B
GEF.B
$4.21B
| $818K | ﹤0.01% |
13,516
+365
| +3% | +$19.9K |
|
2985
C&F Financial
CFFI
$286M
| $817K | ﹤0.01% |
18,968
+240
| +1% | +$10.6K |
|
2986
Shore Bancshares
SHBI
$796M
| $816K | ﹤0.01% |
69,327
+9,677
| +16% | +$113K |
|
|
EGIO
2987
DELISTED
Edgio, Inc. Common Stock
EGIO
| $811K | ﹤0.01% |
10,848
+176
| +2% | +$11.9K |
|
|
MITL
2988
DELISTED
Mitel Networks Corporation
MITL
| $811K | ﹤0.01% |
110,289
+59,618
| +118% | +$439K |
|
|
DALN
2989
DELISTED
DallasNews
DALN
| $810K | ﹤0.01% |
27,582
+108
| +0.4% | +$2.56K |
|
|
ITIC
2990
Investors Title Co
ITIC
$547M
| $810K | ﹤0.01% |
8,148
+289
| +4% | +$28.4K |
|
|
ASXC
2991
DELISTED
Asensus Surgical, Inc.
ASXC
| $809K | ﹤0.01% |
36,867
+1,077
| +3% | +$19.7K |
|
|
TTOO
2992
DELISTED
T2 Biosystems, Inc
TTOO
| $809K | ﹤0.01% |
22
| – | – |
|
2993
Fortress Biotech
FBIO
$88.7M
| $807K | ﹤0.01% |
18,120
+549
| +3% | +$23.3K |
|
2994
Cytosorbents Corp
CTSO
$22.6M
| $805K | ﹤0.01% |
125,873
+101
| +0.1% | +$525 |
|
2995
Southern Missouri Bancorp
SMBC
$850M
| $801K | ﹤0.01% |
32,172
+409
| +1% | +$10.1K |
|
|
EGLT
2996
DELISTED
Egalet Corporation
EGLT
| $801K | ﹤0.01% |
105,282
+24,325
| +30% | +$174K |
|
|
KA
2997
DELISTED
Kineta, Inc. Common Stock
KA
| $800K | ﹤0.01% |
367
+24
| +7% | +$44.6K |
|
|
HTCH
2998
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
| $800K | ﹤0.01% |
201,239
+9,791
| +5% | +$22.2K |
|
2999
First Internet Bancorp
INBK
$255M
| $796K | ﹤0.01% |
34,474
+8,584
| +33% | +$203K |
|
|
AGRX
3000
DELISTED
Agile Therapeutics
AGRX
| $796K | ﹤0.01% |
57
+13
| +30% | +$186K |
|
Similar funds
Geode Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Geode Capital Management held 4,151 positions worth $199B, up 8% from $184B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management deployed $6.96B of net new capital in Q3 2016, opening 137 new positions and adding to 3,049 existing holdings. Its largest new stake was Fortive: 4,005,895 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $103M trimmed.
- Geode Capital Management's largest Q3 2016 buy was Fortive: 4,005,895 shares worth $128M.
- Geode Capital Management added most to Johnson & Johnson in Q3 2016, an estimated $150M increase.
- Geode Capital Management's biggest Q3 2016 reduction was Danaher, cutting an estimated $103M.
- Geode Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $437M.
- Geode Capital Management's ten largest holdings make up 15% of its $199B portfolio in Q3 2016.
- Geode Capital Management opened 137 new positions and closed 123 in Q3 2016.
- Geode Capital Management's portfolio value rose 8% quarter-over-quarter to $199B.
Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.